NASDAQ:ZIOP - ZIOPHARM Oncology Price Target & Analyst Ratings

$5.22
0.00 (0.00 %)
(As of 06/17/2019 03:43 AM ET)
Today's Range
$5.19
Now: $5.22
$5.52
50-Day Range
$4.07
MA: $4.42
$5.45
52-Week Range
$1.56
Now: $5.22
$5.52
Volume3.48 million shs
Average Volume1.48 million shs
Market Capitalization$847.15 million
P/E RatioN/A
Dividend YieldN/A
Beta2.52

Analyst Ratings

ZIOPHARM Oncology (NASDAQ:ZIOP) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for ZIOPHARM Oncology in the last 12 months. Their average twelve-month price target is $6.25, suggesting that the stock has a possible upside of 19.73%. The high price target for ZIOP is $7.50 and the low price target for ZIOP is $5.00. There are currently 1 sell rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.602.602.332.33
Ratings Breakdown: 1 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.25$6.25$5.50$5.50
Price Target Upside: 19.73% upside41.72% upside82.72% upside82.72% upside

ZIOPHARM Oncology (NASDAQ:ZIOP) Consensus Price Target History

Price Target History for ZIOPHARM Oncology (NASDAQ:ZIOP)

ZIOPHARM Oncology (NASDAQ:ZIOP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/9/2019HC WainwrightReiterated RatingBuy$5.50MediumView Rating Details
4/4/2019Lake Street CapitalInitiated CoverageBuy ➝ Buy$7.00MediumView Rating Details
4/1/2019LaidlawInitiated CoverageBuy ➝ Buy$7.50HighView Rating Details
11/15/2018Raymond JamesUpgradeMarket Perform ➝ Outperform$5.00MediumView Rating Details
6/18/2018JPMorgan Chase & Co.DowngradeNeutral ➝ UnderweightLowView Rating Details
(Data available from 6/17/2017 forward)
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Featured Article: Outperform Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel